Topicals represent 5.1% of total prescriptions and 14% of total drug cost, and are being prescribed as an alternative to some oral medications. Within this class, cost drivers including prescription (Rx) and private label topical analgesics (PLTAs) are associated with limited clinical efficacy and exorbitant pricing that often eliminates them as a favorable first-line therapy option. These and other challenges call for careful oversight that includes identification, clinical review and intervention, and/or recommendation of therapeutic alternatives where appropriate to help control inappropriate utilization and spend. Watch the video blog to learn more.
More stories
Auto Casualty
Article
Modernizing Claims Management: Streamlining Workflows With Integrated Negotiation Solutions
Negotiation Solutions Conventionally, the process of settling bodily injury claim
Workers' Comp
Article
Rising Temperatures and Rising Risks: Ensuring Workplace Safety with Enlyte's ClinicalCare24
As temperatures climb, so do the risks of workplace injuries related to heat.
Workers' Comp
Article
Specialty Solutions Spotlight: Emerging Workers' Comp Technology Trends
How are emerging technologies and trends in workers’ comp impacting workplace safety and rehabilitation? Technology and workplace safety
Workers' Comp
Case Study
Returning to the Same Employer in a Different Job
Workers' Comp
Article
Top Trends in P&C Networks
Workers' Comp
Case Study